γδ T cell receptor deficiency attenuated cardiac allograft vasculopathy and promoted regulatory T cell expansion

Scandinavian Journal of Immunology

Volumn 78, Issue 1, 2013, Pages 44-49

  Zhu, H ^a   Li, J ^b   Wang, S ^c   Liu, K ^a   Wang, L ^a   Huang, L ^a  

^a WUHAN UNIVERSITY   (China)

^b Wuhan Central Hospital   (China)

^c HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; GAMMA INTERFERON; HIGH MOBILITY GROUP B1 PROTEIN; INTERLEUKIN 17; INTERLEUKIN 2 RECEPTOR ALPHA; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR FOXP3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIAC ALLOGRAFT VASCULOPATHY; CARDIAC GRAFT REJECTION; CELL EXPANSION; CONTROLLED STUDY; DISEASE ASSOCIATION; GAMMA DELTA T LYMPHOCYTE; GRAFT SURVIVAL; HEART MUSCLE CONTRACTILITY; HEART TRANSPLANTATION; HISTOPATHOLOGY; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SURVIVAL TIME; T CELL DEPLETION; WILD TYPE;

ANIMALS; FORKHEAD TRANSCRIPTION FACTORS; GRAFT SURVIVAL; HEART TRANSPLANTATION; HMGB1 PROTEIN; INTERFERON-GAMMA; INTERLEUKIN-17; MICE; MICE, INBRED C57BL; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; T-LYMPHOCYTES, REGULATORY; TRANSPLANTATION, HOMOLOGOUS; VASCULAR DISEASES;

EID: 84880320025     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/sji.12064     Document Type: Article

References (36)

1. Weis M, von Scheidt W. Cardiac allograft vasculopathy: a review. Circulation 1997;96:2069-77.
2. Cua DJ, Tato CM. Innate IL-17-producing cells: the sentinels of the immune system. Nat Rev Immunol 2010;10:479-89.
3. Russell SE, Walsh PT. Sterile inflammation - do innate lymphoid cell subsets play a role? Front Immunol 2012;3:246.
4. Malan Borel I, Racca A, Garcia MI et al. Gammadelta T cells and interleukin-6 levels could provide information regarding the progression of human renal allograft. Scand J Immunol 2003;58:99-105.
5. Koshiba T, Li Y, Takemura M et al. Clinical, immunological, and pathological aspects of operational tolerance after pediatric living-donor liver transplantation. Transpl Immunol 2007;17:94-7.
6. Malone F, Carper K, Reyes J, Li W. Gammadelta T cells are involved in liver transplant tolerance. Transplant Proc 2009;41:233-5.
7. DeFina RA, Liang Y, He H et al. Analysis of immunoglobulin and T-cell receptor gene deficiency in graft rejection by gene expression profiles. Transplantation 2004;77:580-6.
8. Li J, Zhu H, Wang S et al. Blockade of NKG2D synergized with CTLA4-Ig in promoting long-term graft survival in murine models of cardiac transplantation. Transplantation 2012;93:356-63.
9. Kimura N, Nakae S, Itoh S et al. Potential role of gammadelta T cell-derived IL-17 in acute cardiac allograft rejection. Ann Thorac Surg 2012;94:542-8.
10. Corry RJ, Winn HJ, Russell PS. Primarily vascularized allografts of hearts in mice. The role of H-2D, H-2K, and non-H-2 antigens in rejection. Transplantation 1973;16:343-50.
11. Bakir HY, Tomiyama-Miyaji C, Watanabe H et al. Reasons why DBA/2 mice are resistant to malarial infection: expansion of CD3int B220+ gammadelta T cells with double-negative CD4- CD8- phenotype in the liver. Immunology 2006;117:127-35.
12. Setiady YY, Coccia JA, Park PU. In vivo depletion of CD4+FOXP3+ Treg cells by the PC61 anti-CD25 monoclonal antibody is mediated by FcgammaRIII+ phagocytes. Eur J Immunol 2010;40:780-6.
13. Holschermann H, Bohle RM, Zeller H et al. In situ detection of tissue factor within the coronary intima in rat cardiac allograft vasculopathy. Am J Pathol 1999;154:211-20.
14. Jun L, Kailun Z, Aini X et al. Combined treatment with chemokine receptor 5 blocker and cyclosporine induces prolonged graft survival in a mouse model of cardiac transplantation. J Heart Lung Transplant 2010;29:461-70.
15. Li J, Chen G, Ye P et al. CCR5 blockade in combination with cyclosporine increased cardiac graft survival and generated alternatively activated macrophages in primates. J Immunol 2011;186:3753-61.
16. Gorbacheva V, Fan R, Li X, Valujskikh A. Interleukin-17 promotes early allograft inflammation. Am J Pathol 2010;177:1265-73.
17. Duan L, Wang CY, Chen J et al. High-mobility group box 1 promotes early acute allograft rejection by enhancing IL-6-dependent Th17 alloreactive response. Lab Invest 2011;91:43-53.
18. Schnickel GT, Bastani S, Hsieh GR et al. Combined CXCR3/CCR5 blockade attenuates acute and chronic rejection. J Immunol 2008;180:4714-21.
19. Magil AB. Monocytes/macrophages in renal allograft rejection. Transplant Rev (Orlando) 2009;23:199-208.
20. Taylor PR, Martinez-Pomares L, Stacey M, Lin HH, Brown GD, Gordon S. Macrophage receptors and immune recognition. Annu Rev Immunol 2005;23:901-44.
21. Wyburn KR, Jose MD, Wu H, Atkins RC, Chadban SJ. The role of macrophages in allograft rejection. Transplantation 2005;80:1641-7.
22. Bustin M. Regulation of DNA-dependent activities by the functional motifs of the high-mobility-group chromosomal proteins. Mol Cell Biol 1999;19:5237-46.
23. Andersson A, Covacu R, Sunnemark D et al. Pivotal advance: HMGB1 expression in active lesions of human and experimental multiple sclerosis. J Leukoc Biol 2008;84:1248-55.
24. Huang Y, Yin H, Han J et al. Extracellular hmgb1 functions as an innate immune-mediator implicated in murine cardiac allograft acute rejection. Am J Transplant 2007;7:799-808.
25. Dallman MJ, Larsen CP, Morris PJ. Cytokine gene transcription in vascularised organ grafts: analysis using semiquantitative polymerase chain reaction. J Exp Med 1991;174:493-6.
26. Saiura A, Mataki C, Murakami T et al. A comparison of gene expression in murine cardiac allografts and isografts by means DNA microarray analysis. Transplantation 2001;72:320-9.
27. Tellides G, Tereb DA, Kirkiles-Smith NC et al. Interferon-gamma elicits arteriosclerosis in the absence of leukocytes. Nature 2000;403:207-11.
28. Koh KP, Wang Y, Yi T et al. T cell-mediated vascular dysfunction of human allografts results from IFN-gamma dysregulation of NO synthase. J Clin Invest 2004;114:846-56.
29. Itoh S, Kimura N, Axtell RC et al. Interleukin-17 accelerates allograft rejection by suppressing regulatory T cell expansion. Circulation 2011;124:S187-96.
30. Burrell BE, Csencsits K, Lu G, Grabauskiene S, Bishop DK. CD8+ Th17 mediate costimulation blockade-resistant allograft rejection in T-bet-deficient mice. J Immunol 2008;181:3906-14.
31. Nath DS, Tiriveedhi V, Basha HI et al. A role for antibodies to human leukocyte antigens, collagen-V, and K-alpha1-Tubulin in antibody-mediated rejection and cardiac allograft vasculopathy. Transplantation 2011;91:1036-43.
32. Itoh S, Nakae S, Axtell RC et al. IL-17 contributes to the development of chronic rejection in a murine heart transplant model. J Clin Immunol 2012;30:235-40.
33. Groux H, O'Garra A, Bigler M et al. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 1997;389:737-42.
34. Itoh M, Takahashi T, Sakaguchi N et al. Thymus and autoimmunity: production of CD25+CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance. J Immunol 1999;162:5317-26.
35. Wood KJ, Sakaguchi S. Regulatory T cells in transplantation tolerance. Nat Rev Immunol 2003;3:199-210.
36. Zhao X, Li Y, Ohe H et al. Intragraft Vdelta1 gammadelta T cells with a unique T-cell receptor are closely associated with pediatric semiallogeneic liver transplant tolerance. Transplantation 2013;95:192-202.